Effectiveness of Natalizumab in Relapsing Remitting Multiple Sclerosis: An Observational Study from a Tertiary Referral Tunisian Center

被引：0
作者：
Majoul, Mohamed Slim [1 ]
Zouari, Rania [1 ]
Becha, Mariem [1 ]
Rachdi, Amine [1 ]
Saied, Mohamed Zakaria [1 ]
Ben Mohamed, Dina [1 ]
Ben Sassi, Samia [1 ]
机构：
[1] Natl Inst Mongi Ben Hmida Neurol, Dept Neurol, Tunis, Tunisia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1679/1016
引用
收藏
页码：1061 / 1062
页数：2
相关论文
共 50 条
  • [41] Graves’ disease induced by Alemtuzumab in relapsing–remitting multiple sclerosis patients: an observational study in a reference center
    P. Rodríguez de Vera Gómez
    J. J. García-González
    R. Ravé-García
    R. López Ruiz
    A. Torres-Cuadro
    S. Eichau-Madueño
    C. García-García
    T. Martín-Hernández
    Journal of Endocrinological Investigation, 2022, 45 : 1977 - 1990
  • [42] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [43] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [44] Natalizumab in a case of relapsing remitting multiple sclerosis and neurofibromatosis type 1
    Corea, Francesco
    Ciotti, Silvia
    Baldini, Alessandra
    Zampolini, Mauro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [45] USING NATALIZUMAB IN HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS IN THE UK
    Nicholas, R.
    D'Arcy, C.
    Muraro, P.
    McGuigan, C.
    Malik, O.
    Giannetti, P.
    O'Driscoll, S.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11) : E53 - E53
  • [46] The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
    Curti, Erica
    Tsantes, Elena
    Baldi, Eleonora
    Caniatti, Luisa Maria
    Ferraro, Diana
    Sola, Patrizia
    Granella, Franco
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 146 - 152
  • [47] Effectiveness and safety of alemtuzumab in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
    Brecl Jakob, Gregor
    Barun, Barbara
    Gomezelj, Sarah
    Gabelic, Tereza
    Sega Jazbec, Sasa
    Adamec, Ivan
    Horvat Ledinek, Alenka
    Rot, Uros
    Krbot Skoric, Magdalena
    Habek, Mario
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4591 - 4597
  • [48] Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
    Kalincik, Tomas
    Brown, J. William L.
    Robertson, Neil
    Willis, Mark
    Scolding, Neil
    Rice, Claire M.
    Wilkins, Alastair
    Pearson, Owen
    Ziemssen, Tjalf
    Hutchinson, Michael
    McGuigan, Christopher
    Jokubaitis, Vilija
    Spelman, Tim
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Izquierdo, Guillermo
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Alroughani, Raed
    Pucci, Eugenio
    Sola, Patrizia
    Hupperts, Raymond
    Lechner-Scott, Jeannette
    Terzi, Murat
    Van Pesch, Vincent
    Rozsa, Csilla
    Grand'Maison, Francois
    Boz, Cavit
    Granella, Franco
    Slee, Mark
    Spitaleri, Daniele
    Olascoaga, Javier
    Bergamaschi, Roberto
    Verheul, Freek
    Vucic, Steve
    McCombe, Pamela
    Hodgkinson, Suzanne
    Sanchez-Menoyo, Jose Luis
    Ampapa, Radek
    Simo, Magdolna
    Csepany, Tunde
    Ramo, Cristina
    Cristiano, Edgardo
    Barnett, Michael
    Butzkueven, Helmut
    Coles, Alasdair
    LANCET NEUROLOGY, 2017, 16 (04) : 271 - 281
  • [49] Natalizumab Treatment for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia
    Algahtani, Hussein
    Shirah, Bader
    Abobaker, Hind
    Alghanaim, Nebras
    Kamel, Fatemah
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (06) : 199 - 201
  • [50] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
12345